Literature DB >> 20660754

Stalking influenza.

Debra M Eckert1, Michael S Kay.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20660754      PMCID： PMC2922238          DOI： 10.1073/pnas.1008672107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

1.  Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography.

Authors:  N K Sauter; J E Hanson; G D Glick; J H Brown; R L Crowther; S J Park; J J Skehel; D C Wiley
Journal:  Biochemistry       Date:  1992-10-13       Impact factor: 3.162

Review 2.  Research and development of universal influenza vaccines.

Authors:  Lanying Du; Yusen Zhou; Shibo Jiang
Journal:  Microbes Infect       Date:  2010-01-15       Impact factor: 2.700

3.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

4.  Origin and evolution of influenza virus hemagglutinin genes.

Authors:  Yoshiyuki Suzuki; Masatoshi Nei
Journal:  Mol Biol Evol       Date:  2002-04       Impact factor: 16.240

5.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.

Authors:  D C Wiley; I A Wilson; J J Skehel
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

6.  Protein minimization of the gp120 binding region of human CD4.

Authors:  Deepak Sharma; M M Balamurali; Kausik Chakraborty; Sowmini Kumaran; Sadasivam Jeganathan; Umar Rashid; Paolo Ingallinella; Raghavan Varadarajan
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

7.  Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.

Authors:  Taia T Wang; Gene S Tan; Rong Hai; Natalie Pica; Erin Petersen; Thomas M Moran; Peter Palese
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

8.  Influenza virus vaccine based on the conserved hemagglutinin stalk domain.

Authors:  John Steel; Anice C Lowen; Taia T Wang; Mark Yondola; Qinshan Gao; Kester Haye; Adolfo García-Sastre; Peter Palese
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

Review 9.  Variation and infectivity neutralization in influenza.

Authors:  Marcel Knossow; John J Skehel
Journal:  Immunology       Date:  2006-09       Impact factor: 7.397

10.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Authors:  Mark Throsby; Edward van den Brink; Mandy Jongeneelen; Leo L M Poon; Philippe Alard; Lisette Cornelissen; Arjen Bakker; Freek Cox; Els van Deventer; Yi Guan; Jindrich Cinatl; Jan ter Meulen; Ignace Lasters; Rita Carsetti; Malik Peiris; John de Kruif; Jaap Goudsmit
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240
View more
  4 in total

1.  Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection.

Authors:  Zuzana Staneková; Vojtech Mucha; Tatiana Sládková; Hana Blaškovičová; František Kostolanský; Eva Varečková
Journal:  Influenza Other Respir Viruses       Date:  2012-01-12       Impact factor: 4.380

2.  Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

Authors:  Juine-Ruey Chen; Yueh-Hsiang Yu; Yung-Chieh Tseng; Wan-Ling Chiang; Ming-Feng Chiang; Yi-An Ko; Yi-Kai Chiu; Hsiu-Hua Ma; Chung-Yi Wu; Jia-Tsrong Jan; Kuo-I Lin; Che Ma; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 3.  Cross-reactive human B cell and T cell epitopes between influenza A and B viruses.

Authors:  Masanori Terajima; Jenny Aurielle B Babon; Mary Dawn T Co; Francis A Ennis
Journal:  Virol J       Date:  2013-07-26       Impact factor: 4.099

4.  Inhibition of influenza A virus infection in vitro by peptides designed in silico.

Authors:  Rogelio López-Martínez; G Lizbeth Ramírez-Salinas; José Correa-Basurto; Blanca L Barrón
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.